We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
Cap. Flow
-$778M
Cap. Flow %
-13.04%
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$51.8M
2
V icon
Visa
V
+$46.4M
3
CMCSA icon
Comcast
CMCSA
+$45.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$36.3M
5
NSC icon
Norfolk Southern
NSC
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Industrials 13.43%
3 Financials 12.16%
4 Consumer Discretionary 11.52%
5 Healthcare 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRN
851
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
$114K ﹤0.01%
+12,900
New +$115K
MDCI
852
DELISTED
MEDICAL ACTION INDS INC
MDCI
$114K ﹤0.01%
+16,300
New +$122K
BXC icon
853
BlueLinx
BXC
$455M
$113K ﹤0.01%
8,686
+4,216
+94% +$65.9K
UTIW
854
DELISTED
UTI WORLDWIDE INC
UTIW
$112K ﹤0.01%
+10,600
New +$151K
PSTB
855
DELISTED
Park Sterling Corp.
PSTB
$109K ﹤0.01%
16,394
-2,500
-13% -$16.9K
PCTI
856
DELISTED
PCTEL, Inc. Common Stock
PCTI
$97K ﹤0.01%
11,141
-9,821
-47% -$84.8K
INOD icon
857
Innodata
INOD
$1.83B
$90K ﹤0.01%
30,772
-17,581
-36% -$52.1K
RFMD
858
DELISTED
RF MICRO DEVICES INC
RFMD
$89K ﹤0.01%
11,260
-479,189
-98% -$2.95M
ABCD
859
DELISTED
Cambium Learning Group, Inc.
ABCD
$88K ﹤0.01%
41,373
NWY
860
DELISTED
New York & Co Inc
NWY
$84K ﹤0.01%
19,113
-175,309
-90% -$785K
TECUA
861
DELISTED
TECUMSEH PRODUCTS CO CL-A
TECUA
$84K ﹤0.01%
12,209
-17,500
-59% -$120K
AXTI icon
862
AXT Inc
AXTI
$3.09B
$78K ﹤0.01%
+35,361
New +$83.8K
VTG
863
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
$78K ﹤0.01%
+45,900
New +$80K
VVTV
864
DELISTED
VALUEVISION MEDIA INC
VVTV
$74K ﹤0.01%
+15,300
New +$90.1K
ENZ
865
DELISTED
Enzo Biochem, Inc.
ENZ
$65K ﹤0.01%
15,600
-1,000
-6% -$3.43K
ARQL
866
DELISTED
Arqule Inc
ARQL
$65K ﹤0.01%
+31,621
New +$70.9K
MEET
867
DELISTED
The Meet Group, Inc. Common Stock
MEET
$64K ﹤0.01%
19,500
-43,400
-69% -$116K
IDXG
868
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$59K ﹤0.01%
129
-109
-46% -$56.6K
INVE icon
869
Identive
INVE
$64.6M
$58K ﹤0.01%
5,130
-2,780
-35% -$24.7K
ALXA
870
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$55K ﹤0.01%
+12,500
New +$64.1K
ANTH
871
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$49K ﹤0.01%
+1,825
New +$46.3K
IKAN
872
DELISTED
IKANOS COMMUNICATIONS INC COM STK NEW (DE)
IKAN
$46K ﹤0.01%
5,333
CTIC
873
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$46K ﹤0.01%
1,340
GERN icon
874
Geron
GERN
$911M
$21K ﹤0.01%
10,792
AAT
875
American Assets Trust
AAT
$1.49B
-48,669
Closed -$1.53M

Similar funds

Jacobs Levy Equity Management's Q1 2014 Portfolio in Review

As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.

  • Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
  • Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
  • Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
  • Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
  • Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
  • Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.